CorMedix Inc. (NASDAQ: CRMD)
$4.99
+0.0900 ( +1.84% ) 583.4K
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
Market Data
Open
$4.99
Previous close
$4.90
Volume
583.4K
Market cap
$274.80M
Day range
$4.88 - $5.03
52 week range
$2.57 - $7.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 14, 2023 |
3 | Insider transactions | 1 | Dec 14, 2023 |
4 | Insider transactions | 1 | Nov 21, 2023 |
4 | Insider transactions | 1 | Nov 17, 2023 |
8-k | 8K-related | 14 | Nov 16, 2023 |
10-q | Quarterly Reports | 48 | Nov 14, 2023 |
8-k | 8K-related | 14 | Nov 14, 2023 |
8-k | 8K-related | 12 | Oct 30, 2023 |
ars | Annual reports | 1 | Sep 13, 2023 |
def | Proxies and info statements | 5 | Sep 13, 2023 |